Theralase Technologies Inc (TLTFF)

[was CUIN2]

This is telling: Theralase looks forward to successfully reporting out on the performance to the primary and secondary endpoints for the next 6 patients and also the exploratory objective of efficacy of all nine patients, as more clinical data is collected. Theralase has now successfully transformed from a pre-clinical to a clinical oncology organization.”

Efficacy on all 9, including current 3.